GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicell Inc (FRA:OC9) » Definitions » Cyclically Adjusted PB Ratio

Omnicell (FRA:OC9) Cyclically Adjusted PB Ratio : 1.41 (As of Jun. 11, 2024)


View and export this data going back to . Start your Free Trial

What is Omnicell Cyclically Adjusted PB Ratio?

As of today (2024-06-11), Omnicell's current share price is €27.40. Omnicell's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €19.47. Omnicell's Cyclically Adjusted PB Ratio for today is 1.41.

The historical rank and industry rank for Omnicell's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:OC9' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.28   Med: 4.45   Max: 11.78
Current: 1.4

During the past years, Omnicell's highest Cyclically Adjusted PB Ratio was 11.78. The lowest was 1.28. And the median was 4.45.

FRA:OC9's Cyclically Adjusted PB Ratio is ranked better than
64.65% of 331 companies
in the Healthcare Providers & Services industry
Industry Median: 2.01 vs FRA:OC9: 1.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Omnicell's adjusted book value per share data for the three months ended in Mar. 2024 was €23.812. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €19.47 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Omnicell Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Omnicell's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicell Cyclically Adjusted PB Ratio Chart

Omnicell Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.62 8.75 11.14 2.71 1.83

Omnicell Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.05 3.72 2.22 1.83 1.38

Competitive Comparison of Omnicell's Cyclically Adjusted PB Ratio

For the Health Information Services subindustry, Omnicell's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicell's Cyclically Adjusted PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Omnicell's Cyclically Adjusted PB Ratio falls into.



Omnicell Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Omnicell's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=27.40/19.47
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omnicell's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Omnicell's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=23.812/131.7762*131.7762
=23.812

Current CPI (Mar. 2024) = 131.7762.

Omnicell Quarterly Data

Book Value per Share CPI Adj_Book
201406 7.748 100.560 10.153
201409 8.258 100.428 10.836
201412 8.833 99.070 11.749
201503 10.346 99.621 13.685
201506 9.925 100.684 12.990
201509 9.854 100.392 12.935
201512 10.378 99.792 13.704
201603 10.278 100.470 13.481
201606 10.178 101.688 13.190
201609 10.434 101.861 13.498
201612 11.169 101.863 14.449
201703 11.054 102.862 14.161
201706 10.684 103.349 13.623
201709 10.455 104.136 13.230
201712 12.188 104.011 15.442
201803 11.990 105.290 15.006
201806 12.853 106.317 15.931
201809 13.396 106.507 16.574
201812 14.811 105.998 18.413
201903 15.689 107.251 19.277
201906 16.435 108.070 20.040
201909 17.498 108.329 21.285
201912 18.056 108.420 21.946
202003 18.660 108.902 22.580
202006 18.431 108.767 22.330
202009 18.444 109.815 22.133
202012 18.589 109.897 22.290
202103 19.672 111.754 23.196
202106 20.113 114.631 23.121
202109 21.533 115.734 24.518
202112 22.971 117.630 25.734
202203 22.091 121.301 23.999
202206 23.339 125.017 24.601
202209 25.685 125.227 27.028
202212 23.842 125.222 25.090
202303 23.678 127.348 24.501
202306 23.758 128.729 24.320
202309 24.473 129.860 24.834
202312 23.941 129.419 24.377
202403 23.812 131.776 23.812

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Omnicell  (FRA:OC9) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Omnicell Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Omnicell's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicell (FRA:OC9) Business Description

Traded in Other Exchanges
Address
2625 Augustine Drive, Suite 301, Santa Clara, CA, USA, 95054
Omnicell Inc provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.

Omnicell (FRA:OC9) Headlines

No Headlines